Tin tức & Cập nhật
Xem bài viết Nhãn khoa
Xem
Chỉ hiển thị Multimedia

Investigational nasal spray for dry eye disease scores high in phase II trial
16 Aug 2022
The single-dose nicotinic acetylcholine receptor agonist OC-02, administered as an aqueous nasal spray, helps increase tear production and improve eye dryness in patients with dry eye disease (DED), according to data from the phase II PEARL trial.
16 Aug 2022







